MDMA self-administration in rats: Acquisition, progressive ratio responding and serotonin transporter binding

European Journal of Neuroscience

Volumn 26, Issue 11, 2007, Pages 3229-3236

  Schenk, Susan ^a   Hely, Lincoln ^a   Lake, Barbara ^a   Daniela, Evangelene ^a   Gittings, David ^a   Mash, Deborah C ^b  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Drug reinforcement; MDMA abuse; Neuroadaptation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; PAROXETINE; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; LIGAND BINDING; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR DENSITY;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PAROXETINE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRITIUM;

EID: 36248966996     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05932.x     Document Type: Article

References (53)

1. Amato, J.L., Bankson, M.G. Yamamoto, B.K. (2007) Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology, 32, 946 954.
2. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res., 486, 261 268.
3. Banks, M.L., Czoty, P.W., Gage, H.D., Bounds, M.C., Garg, P.K., Garg, S. Nader, M.A. (2007) Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Neuropsychopharmacology, doi :.
4. Battaglia, G., Yeh, S.Y., O'Hearn, E., Molliver, M.E., Kuhar, M.J. De Souza, E.B. (1987) 3,4-Methylenedioxymethamphetamine and 3,4- methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther., 242, 911 916.
5. Baumann, M.H., Wang, X. Rothman, R.B. (2007) 3,4- Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology, 10.1007/s00213-006-0322-6.
6. Beardsley, P.M., Balster, R.L. Harris, L.S. (1986) Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend., 18, 149 157.
7. Braida, D. Sala, M. (2002) Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. Br. J. Pharmacol., 136, 1089 1092.
8. Buchert, R., Thomasius, R., Wilke, F., Petersen, K., Nebeling, B., Obrocki, J., Schulze, O., Schmidt, U. Clausen, M. (2004) A voxel-based PET investigation of the long-term effects of 'Ecstasy' consumption on brain serotonin transporters. Am. J. Psychiatry, 161, 1181 1189.
9. Cadoni, C., Solinas, M., Pisanu, A., Zernig, G., Acquas, E. Di Chiara, G. (2005) Effect of 3,4-methylendioxymethamphetamine (MDMA, 'ecstasy') on dopamine transmission in the nucleus accumbens shell and core. Brain Res., 1055, 143 148.
10. Carlezon, W.A. Wise, R.A. (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci., 16, 3112 3122.
11. Carroll, M.E. Lac, S.T. (1997) Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology, 129, 206 214.
12. Colado, M.I., Camarero, J., Mechan, A.O., Sanchez, V., Esteban, B., Elliott, J.M. Green, A.R. (2001) A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Br. J. Pharmacol., 134, 1711 1723.
13. Cole, J.C. Sumnall, H.R. (2003) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci. Biobehav. Rev., 27, 199 217.
14. Cowan, R.L. (2007) Neuroimaging research in human MDMA users: a review. Psychopharmacology, 189, 539 556.
15. Dalley, J.W., Laane, K., Theobold, D.E.H., Pena, Y., Bruce, C.C., Huszar, A.C., Wojcieszek, M., Everitt, B.J. Robbins, T.W. (2007) Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropyschopharmacology, 32, 1195 1206.
16. Daniela, E., Brennan, K., Gittings, D., Hely, L. Schenk, S. (2004) Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol. Biochem. Behav., 77, 745 750.
17. Daniela, E., Gittings, D. Schenk, S. (2006) Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration. Behav. Neurosci., 120, 1144 1150.
18. De La Garza 2nd, R., Fabrizio, K.R. Gupta, A. (2007) Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology, 189, 425 434.
19. Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M.A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V. Lecca, D. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology, 47 (Suppl 1 227 241.
20. Fantegrossi, W.E., Ullrich, T., Rice, K.C., Woods, J.H. Winger, G. (2002) 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology, 161, 356 364.
21. Fantegrossi, W.E., Woolverton, W.L., Kilbourn, M., Sherman, P., Yuan, J., Hatzidimitriou, G., Ricaurte, G.A., Woods, J.H. Winger, G. (2004) Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology, 29, 1270 1281.
22. Fischer, C., Hatzidimitriou, G., Wlos, J., Katz, J. Ricaurte, G. (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). J. Neurosci., 15, 5476 5485.
23. Hemby, S.E., Co, C., Koves, T.R., Smith, J.E. Dworkin, S.I. (1997) Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology, 133, 7 16.
24. Horger, B.A., Shelton, K. Schenk, S. (1990) Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav., 37, 707 711.
25. Itzhak, Y., Ali, S.F., Achat, C.N. Anderson, K.L. (2003) Relevance of MDMA ('ecstasy')-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacology, 166, 241 248.
26. Lamb, R.J. Griffiths, R.R. (1987) Self-injection of d,1-3,4- methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology, 91, 268 272.
27. Lecca, D., Cacciapaglia, F., Valentini, V., Acquas, E. Di Chiara, G. (2007) Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology, 191, 653 667.
28. Lecca, D., Cacciapaglia, F., Valentini, V., Gronli, J., Spiga, S. Di Chiara, G. (2006) Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology, 184, 435 446.
29. Lile, J.A., Ross, J.T. Nader, M.A. (2005) A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') with cocaine in rhesus monkeys. Drug Alcohol Depend., 78, 135 140.
30. McCann, U.D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W.B., Ravert, H.T., Dannals, F. Ricaurte, G.A. (2005) Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology, 30, 1741 1750.
31. O'Shea, E., Esteban, B., Camarero, J., Green, A.R. Colado, M.I. (2001) Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology, 40, 65 74.
32. Pontieri, F.E., Tanda, G. Di Chiara, G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc. Natl Acad. Sci. USA, 92, 12304 12308.
33. Ratzenboeck, E., Saria, A., Kriechbaum, N. Zernig, G. (2001) Reinforcing effects of MDMA ('ecstasy') in drug-naive and cocaine-trained rats. Pharmacology, 62, 138 144.
34. Reveron, M.E., Maier, E.Y. Duvauchelle, C.L. (2006) Experience-dependent changes in temperature and behavioral activity induced by MDMA. Physiol. Behav., 89, 358 363.
35. Ricaurte, G.A., Forno, L.S., Wilson, M.A., DeLanney, L.E., Irwin, I., Molliver, M.E. Langston, J.W. (1988) (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA, 260, 51 55.
36. Ricaurte, G.A., Martello, A.L., Katz, J.L. Martello, M.B. (1992) Lasting effects of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J. Pharmacol. Exp. Ther., 261, 616 622.
37. Rodd-Henricks, Z.A., McKinzie, D.L., Li, T.K., Murphy, J.M. McBride, W.J. (2002) Cocaine is self-administered into the shell but not the core of the nucleus accumbens of Wistar rats. J. Pharmacol. Exp. Ther., 303, 1216 1226.
38. Sanchez, V., Camarero, J., Esteban, B., Peter, M.J., Green, A.R. Colado, M.I. (2001) The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br. J. Pharmacol., 134, 46 57.
39. Scanzello, C.R., Hatzidimitriou, G., Martello, A.L., Katz, J.L. Ricaurte, G.A. (1993) Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J. Pharmacol. Exp. Ther., 264, 1484 1491.
40. Schenk, S., Gittings, D., Johnstone, M. Daniela, E. (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology, 169, 21 27.
41. Schenk, S., Horger, B.A., Peltier, R. Shelton, K. (1991) Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res., 543, 227 235.
42. Schenk, S., Valadez, A., McNamara, C., House, D.T., Higley, D., Bankson, M.G., Gibbs, S. Horger, B.A. (1993) Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology, 111, 332 338.
43. Shankaran, M. Gudelsky, G.A. (1999) A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology, 147, 66 72.
44. Stafford, D., LeSage, M.G. Glowa, J.R. (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology, 139, 169 184.
45. Steele, T.D., McCann, U.D. Ricaurte, G.A. (1994) 3,4- Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and toxicology in animals and humans. Addiction, 89, 539 551.
46. Sumnall, H.R., O'Shea, E., Marsden, C.A. Cole, J.C. (2004) The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test. Pharmacol. Biochem. Behav., 77, 805 814.
47. Sur, C., Betz, H. Schloss, P. (1996) Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience, 73, 217 231.
48. Szostak, C., Finlay, J.M. Fibiger, H.C. (1987) Intravenous self-administration of the short-acting benzodiazepine midazolam in the rat. Neuropharmacology, 26, 1673 1676.
49. Trigo, J.M., Panayi, F., Soria, G., Maldonado, R. Robledo, P. (2006) A reliable model of intravenous MDMA self-administration in naive mice. Psychopharmacology, 184, 212 220.
50. Trigo, J.M., Renoir, T., Lanfumey, L., Hamon, M., Lesch, K.P., Robledo, P. Maldonado, R. (2007) 3,4-Methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol. Psychiatry, doi :.
51. Wang, Z. Woolverton, W.L. (2007) Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine. Psychopharmacology, 189, 483 488.
52. Ward, S.J., Morgan, D. Roberts, D.C.S. (2005) Comparison of the reinforcing effects of cocaine and cocaine/heroin combinations under progressive ratio and choice schedules in rats. Neuropsychopharmacology, 30, 286 195.
53. Wee, S., Anderson, K.G., Baumann, M.H., Rothman, R.B., Blough, B.E. Woolverton, W.L. (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J. Pharmacol. Exp. Ther., 313, 848 854.